An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

Clinical Trial ID NCT00109148

Rank	Title	Journal	Year	PubWeight™‹?›
1	The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.	Cell Metab	2008	1.94